Johan Häggblad

Johan Häggblad has extensive work experience in the pharmaceutical industry. Johan started their career in 1989 at Karo Bio AB, where they worked in the fields of biochemistry and pharmacology until 1997. Johan then joined Pharmacia Corporation, where they continued working in pharmacology and business development until 2001. Johan Häggblad then moved to NeuroNova AB, where they worked in pharmacology and business development until 2007. Johan then became the CEO of Pharmalink AB, where they remained for 10 years until 2017. Currently, they are the Chief Scientific Officer at Calliditas Therapeutics AB, where they also served as the Vice President of Licensing, IP & Legal from 2017 to 2019.

Johan Häggblad has attended Stockholm University, New York University, University of Oxford, and the University of Warwick's Warwick Business School. However, no specific degree or field of study information is provided for any of these educational institutions.